サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1481995

アジア太平洋のビタミンK2市場予測（2030年）：地域別分析 - 製品、剤形、供給源、用途別

Asia Pacific Vitamin K2 Market Forecast to 2030 - Regional Analysis - by Product, Dosage Forms, Source, and Application

出版日
ページ情報
英文 93 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
アジア太平洋のビタミンK2市場予測（2030年）：地域別分析 - 製品、剤形、供給源、用途別
出版日: 2024年03月04日
発行: The Insight Partners
ページ情報: 英文 93 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋のビタミンK2の市場規模は、2022年に2,005万米ドルに達し、2022年～2030年にCAGR32.3%で成長し、2030年には1億8,793万米ドルに達すると予測されています。

流通チャネルの拡大がアジア太平洋のビタミンK2市場を後押し

ビタミンK2の流通チャネルを拡大することで、この必須栄養素をより多くの人々が利用できるようになります。製造業者と密接に協力することで、ビタミンK2製品の生産と供給を確実に増やし、需要の増加に対応することができます。薬局、健康ショップ、スーパーマーケット、サプリメント専門店などの加盟店への流通は、卸売業者と関係を結ぶことで容易になります。さらに、小売店の店頭で商品の陳列や啓発資料を見ることで、顧客にビタミンK2の価値を知ってもらうことができます。また、新興経済諸国を拠点とするEコマース企業やウェブベースのプラットフォームと協力して、ビタミンK2を含むサプリメントやその他の商品をオンラインで簡単に購入できる方法を顧客に提供することも重要です。

さらに、日常の食事や飲み物にビタミンK2を取り入れることを奨励することで、サプリメントの市場を拡大し、栄養価の高い食事を好む人々がビタミンK2を利用できるようにすることができます。また、医師、栄養士、管理栄養士などのヘルスケア専門家との連携も不可欠であり、これらの専門家は患者にビタミンK2サプリメントの摂取を勧めたり、製品を購入する店舗を薦めたりすることができます。これがビタミンK2の需要を高めています。このように、医療チャネルを通じた流通網の拡大は、今後数年間の市場成長に十分な機会を提供すると期待されています。

アジア太平洋のビタミンK2市場概要

アジア太平洋のビタミンK2市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。市場成長は、CVDの有病率の増加と成人および新生児における骨粗鬆症の骨変形症例の増加に起因しています。しかし、ビタミンK2の利点に関する認知度が低いことが市場成長の妨げとなっています。アジア太平洋市場は、高齢者人口の増加、心血管疾患の増加、革新的な製品の提供などの要因により、予測期間中に大きな成長が見込まれています。その他アジア太平洋には、タイ、ニュージーランド、シンガポール、ミャンマー、ベトナム、フィリピンが含まれます。上記の国々はビタミンK2市場に大きな成長機会を提供しています。

例えば、2019年、シンガポールの人口高齢化に適応する長期ケアシステム報告書によると、同国の人口の14％（すなわち390万人）が65歳以上です。2030年までには、平均寿命の伸びにより25％に達すると予想されており、この人口動態の変化は、同国の医療・介護ニーズに大きな影響を与えます。さらに、ニュージーランドでは、心房細動の発症リスクは加齢とともに増加し、65歳以上の人口の約5％、80歳以上の人口の約10％が発症しています。さらに、これらの国ではヘルスケア支出が増加しています。例えば、マレーシアの医療支出は2017年～2018年に増加し、2018年には2017年から12.22％増加しました。タイの医療費は253億米ドルで、2026年までに479億米ドルの増加が見込まれており、これは10年間のCAGR6.6％を反映しています。このため、予測期間中（2022～2030年）の市場成長はこのような要因によって促進されると予想されます。

アジア太平洋のビタミンK2市場の収益と2030年までの予測

アジア太平洋のビタミンK2市場セグメンテーション

アジア太平洋のビタミンK2市場は、製品、剤形、供給源、用途、国に区分されます。

製品別では、アジア太平洋のビタミンK2市場はMK-4、MK-7、配合剤に区分されます。2022年のアジア太平洋のビタミンK2市場では、MK-7セグメントが最大のシェアを占めています。

剤形別では、アジア太平洋のビタミンK2市場はカプセル・錠剤、粉末、オイルに区分されます。2022年のアジア太平洋のビタミンK2市場は粉末セグメントが最大のシェアを占めています。

供給源別では、アジア太平洋のビタミンK2市場は天然と合成に区分されます。2022年のアジア太平洋のビタミンK2市場は、天然が大きなシェアを占めています。

用途別では、アジア太平洋のビタミンK2市場は医薬品、栄養補助食品、食品、その他に区分されます。医薬品セグメントが2022年のアジア太平洋のビタミンK2市場で最大のシェアを占めています。

国別では、アジア太平洋のビタミンK2市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に区分されます。その他アジア太平洋は2022年にアジア太平洋のビタミンK2市場を独占します。

Balchem Corp、BASF SE、Glanbia Plc、International Flavors &Fragrances Inc、Koninklijke DSM NV、Lesaffre et Cie SA、Lonza Group AG、Novozymes AS、Seebio Biotech（Shanghai）Co Ltdは、アジア太平洋のビタミンK2市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋のビタミンK2市場：主要産業力学

  • 主な市場促進要因
    • CVDの有病率の増加
    • 成人および新生児における骨粗鬆症の症例増加
  • 市場抑制要因
    • ビタミンK2の利点に関する認知不足
  • 市場機会
    • 流通チャネルの拡大
  • 今後の動向
    • 法規制と規格
  • 影響分析

第5章 ビタミンK2市場：アジア太平洋市場分析

  • アジア太平洋のビタミンK2市場収益：2022年～2030年

第6章 アジア太平洋のビタミンK2市場 - 2030年までの収益と予測：製品別

  • アジア太平洋のビタミンK2市場の収益シェア：製品別（2022年・2030年）
  • MK-4
  • MK-7
  • 配合剤

第7章 アジア太平洋のビタミンK2市場 - 2030年までの収益と予測：剤形別

  • アジア太平洋のビタミンK2市場の収益シェア：剤形別（2022年・2030年）
  • カプセル・錠剤
  • 粉末
  • オイル

第8章 アジア太平洋のビタミンK2市場 - 2030年までの収益と予測：供給源別

  • アジア太平洋のビタミンK2市場の収益シェア：供給源別（2022年・2030年）
  • 天然
  • 合成

第9章 アジア太平洋のビタミンK2市場 - 2030年までの収益と予測：用途別

  • アジア太平洋のビタミンK2市場の収益シェア：用途別（2022年・2030年）
  • 医薬品
  • 栄養補助食品と食品
  • その他

第10章 アジア太平洋のビタミンK2市場：国別分析

    • アジア太平洋のビタミンK2市場：国別（2022年・2030年）

第11章 ビタミンK2市場の業界情勢

  • ビタミンK2市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第12章 企業プロファイル

  • Lonza Group AG
  • International Flavors & Fragrances Inc
  • Balchem Corp
  • BASF SE
  • Lesaffre et Cie SA
  • Seebio Biotech（Shanghai）Co Ltd
  • Koninklijke DSM NV
  • Novozymes AS
  • Glanbia Plc

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Vitamin K2 Market Segmentation
  • Table 2. China: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. China: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 4. China: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 5. China: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Japan: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Japan: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Japan: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Japan: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 10. India: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. India: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 12. India: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 13. India: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Australia: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Australia: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Australia: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Australia: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 18. South Korea: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. South Korea: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 20. South Korea: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 21. South Korea: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Dosage Form- Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Source- Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Application- Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Recent Organic Growth Strategies in Vitamin K2 Market
  • Table 27. Recent Inorganic Growth Strategies in the Vitamin K2 Market
  • Table 28. Glossary of Terms, Asia Pacific Vitamin K2 Market

List Of Figures

  • Figure 1. Asia Pacific Vitamin K2 Market Segmentation, By Country
  • Figure 2. Asia Pacific Vitamin K2 Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 6. MK-4: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. MK-7: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Combination Drugs: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Asia Pacific Vitamin K2 Market Revenue Share, by Dosage Form 2022 & 2030 (%)
  • Figure 10. Capsules and Tablets: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Powder: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Oil: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Asia Pacific Vitamin K2 Market Revenue Share, by Source 2022 & 2030 (%)
  • Figure 14. Natural: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Synthetic: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Asia Pacific Vitamin K2 Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 17. Pharmaceuticals: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Nutraceuticals and Food: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Vitamin K2 Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 21. Asia Pacific Vitamin K2 Market, by Country, 2022 & 2030 (%)
  • Figure 22. China: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Japan: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. India: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Australia: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. South Korea: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Rest of Asia Pacific: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Growth Strategies in Vitamin K2 Market
目次
Product Code: BMIRE00029722

The Asia Pacific vitamin K2 market is expected to grow from US$ 20.05 million in 2022 to US$ 187.93 million by 2030. It is estimated to grow at a CAGR of 32.3% from 2022 to 2030.

Expansion of Distribution Channel Fuels Asia Pacific Vitamin K2 Market

Expanding the distribution channels for vitamin K2 can help improve the accessibility of this essential nutrient to a broader population. Working closely with manufacturers ensures increased production and supply of vitamin K2 products to meet the growing demand. The distribution of these items to merchants in pharmacies, health shops, supermarkets, and specialty supplement stores, can be made easier by forming relationships with wholesalers. Additionally, customers can be made aware of the value of vitamin K2 by viewing product displays and educational materials at retail locations. Also, it is critical to work with developing economies-based e-commerce companies and web-based platforms to provide customers with a simple way to buy supplements and other items containing vitamin K2 online.

Furthermore, encouraging the inclusion of vitamin K2 in everyday meals and drinks can broaden the market for supplements, making it more available to people preferring a nutritional diet. Working with healthcare experts such as doctors, nutritionists, and dietitians is also essential, as these experts can advise patients to take vitamin K2 supplements and recommend a store to buy the product. This is raising the demand for vitamin K2. Thus, the expansion of the distribution networks through medical channels is expected to provide ample opportunities for market growth in the coming years.

Asia Pacific Vitamin K2 Market Overview

The Asia Pacific Vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The growth of the market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, the limited awareness regarding benefits of vitamin K2 hinders the market growth. The market in Asia Pacific is expected to witness significant growth during the forecast period due to factors such as rising elderly population, growing cardiovascular diseases, and innovative product availability. The Rest of Asia Pacific includes Thailand, New Zealand, Singapore, Myanmar, Vietnam, and the Philippines. The countries mentioned above offer significant growth opportunities for the vitamin K2 market.

For instance, in 2019, according to Singapore's long-term care system adapting to population aging report, 14% of the country's population (i.e., 3.9 million people) was aged 65 years or older. By 2030, it is expected to reach 25% due to rising life expectancy, and this demographic shift has profound implications for the country's health and care needs. Additionally, in New Zealand, the risk of developing AF increases with age and occurs in about 5% of the population over 65 years and about 10% of people older than 80. Moreover, healthcare expenditure has been observed to increase in these countries. For instance, Malaysia's healthcare spending increased from 2017 to 2018, accounting for US$ 427 in 2018, a 12.22% increase from 2017. Thailand's healthcare expenditure amounts to US$ 25.3 billion, and costs are expected to increase by US$ 47.9 billion by 2026, reflecting a 10-year compound annual growth rate of 6.6%. Therefore, such factors are expected to enhance the market growth during the forecast period (2022-2030).

Asia Pacific Vitamin K2 Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Vitamin K2 Market Segmentation

The Asia Pacific vitamin K2 market is segmented into product, dosage forms, source, application, and country.

Based on product, the Asia Pacific vitamin K2 market is segmented into MK-4, MK-7, and combination drugs. The MK-7 segment held the largest share of the Asia Pacific vitamin K2 market in 2022.

Based on dosage forms, the Asia Pacific vitamin K2 market is segmented into capsules & tablets, powder, and oils. The powder segment held the largest share of the Asia Pacific vitamin K2 market in 2022.

Based on source, the Asia Pacific vitamin K2 market is segmented into natural and synthetic. The natural segment held a larger share of the Asia Pacific vitamin K2 market in 2022.

Based on application, the Asia Pacific vitamin K2 market is segmented into pharmaceuticals, nutraceuticals and food, and others. The pharmaceuticals segment held the largest share of the Asia Pacific vitamin K2 market in 2022.

Based on country, the Asia Pacific vitamin K2 market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The Rest of Asia Pacific dominated the Asia Pacific vitamin K2 market in 2022.

Balchem Corp, BASF SE, Glanbia Plc, International Flavors & Fragrances Inc, Koninklijke DSM NV, Lesaffre et Cie SA, Lonza Group AG, Novozymes AS, and Seebio Biotech (Shanghai) Co Ltd are some of the leading companies operating in the Asia Pacific vitamin K2 market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Vitamin K2 Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of CVD
    • 4.1.2 Growing Cases of Osteoporosis Bone Deformation in Adults and Newborns
  • 4.2 Market Restraints
    • 4.2.1 Limited Awareness Regarding Benefits of Vitamin K2
  • 4.3 Market Opportunities
    • 4.3.1 Expansion of Distribution Channel
  • 4.4 Future Trends
    • 4.4.1 Regulatory Consideration and Standards
  • 4.5 Impact Analysis:

5. Vitamin K2 Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Vitamin K2 Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 - by Product.

  • 6.1 Overview
  • 6.2 Asia Pacific Vitamin K2 Market Revenue Share, by Product 2022 & 2030 (%)
  • 6.3 MK-4
    • 6.3.1 Overview
    • 6.3.2 MK-4: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 MK-7
    • 6.4.1 Overview
    • 6.4.2 MK-7: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Combination Drugs
    • 6.5.1 Overview
    • 6.5.2 Combination Drugs: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 - by Dosage Form.

  • 7.1 Overview
  • 7.2 Asia Pacific Vitamin K2 Market Revenue Share, by Dosage Form, 2022 & 2030 (%)
  • 7.3 Capsules and Tablets
    • 7.3.1 Overview
    • 7.3.2 Capsules and Tablets: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Powder
    • 7.4.1 Overview
    • 7.4.2 Powder: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Oil
    • 7.5.1 Overview
    • 7.5.2 Oil: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 - by Source.

  • 8.1 Overview
  • 8.2 Asia Pacific Vitamin K2 Market Revenue Share, by Source, 2022 & 2030 (%)
  • 8.3 Natural
    • 8.3.1 Overview
    • 8.3.2 Natural: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Synthetic
    • 8.4.1 Overview
    • 8.4.2 Synthetic: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 - by Application.

  • 9.1 Overview
  • 9.2 Asia Pacific Vitamin K2 Market Revenue Share, by Application, 2022 & 2030 (%)
  • 9.3 Pharmaceuticals
    • 9.3.1 Overview
    • 9.3.2 Pharmaceuticals: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Nutraceuticals and Food
    • 9.4.1 Overview
    • 9.4.2 Nutraceuticals and Food: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Vitamin K2 Market - Country Analysis

    • 10.1.1 Asia Pacific Vitamin K2 Market, by Country, 2022 & 2030 (%)
      • 10.1.1.1 China: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 China: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.1.4 China: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.1.5 China: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.1.6 China: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.2 Japan: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Japan: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Japan: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Japan: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.2.6 Japan: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.3 India: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 India: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.3.4 India: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.3.5 India: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.3.6 India: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.4 Australia: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Australia: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.4.4 Australia: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.4.5 Australia: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.4.6 Australia: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.5 South Korea: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.5.4 South Korea: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.5.5 South Korea: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.5.6 South Korea: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)
      • 10.1.1.6 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Product, 2020-2030 (US$ Million)
        • 10.1.1.6.4 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Dosage Form, 2020-2030 (US$ Million)
        • 10.1.1.6.5 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Source, 2020-2030 (US$ Million)
        • 10.1.1.6.6 Rest of Asia Pacific: Asia Pacific Vitamin K2 Market, by Application, 2020-2030 (US$ Million)

11. Vitamin K2 Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Vitamin K2 Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Lonza Group AG
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 International Flavors & Fragrances Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Balchem Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 BASF SE
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Lesaffre et Cie SA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Seebio Biotech (Shanghai) Co Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Koninklijke DSM NV
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Novozymes AS
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Glanbia Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms